Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in individuals with LADA.

Xiajie ShiGan HuangYanfei WangZhenqi LiuChao DengXia LiPeilin ZhengZhiguang Zhou

Published in: Diabetologia (2018)

TSPAN7A are valid islet autoantibodies for use in East Asian populations with autoimmune diabetes and can discriminate individuals with LADA who have lower beta cell function after disease progression.

Keyphrases

systemic lupus erythematosus
multiple sclerosis
type diabetes
single cell
cardiovascular disease
cell therapy
glycemic control
stem cells
mesenchymal stem cells